GHK-Cu (copper tripeptide-1): preparation and storage
Intended for research use only. Not a medicinal product.
Contents (7 sections)
GHK-Cu: copper complex and ligand
GHK-Cu is a copper complex of the Gly-His-Lys tripeptide. Free GHK, a copper salt and preformed GHK-Cu are distinct reagents. The free ligand’s molecular mass cannot automatically be used to calculate complex molarity. The specification should identify composition, copper-to-ligand ratio and the basis of content measurement. Blue colour is compatible with a copper complex but does not establish stoichiometry, purity or stability.
The buffer is part of the experiment’s chemistry. EDTA and other chelators can bind copper; amino acids, serum proteins and pH alter ligand equilibria. Dilution in water and dilution in culture medium therefore do not describe the same chemical system. Mechanistic comparisons should include separate GHK and copper-salt controls with matched copper content and vehicle. Do not acidify or add chelator to correct colour. Where quantitative stability matters, monitor the peptide and copper component with suitable methods.
When comparing batches state whether concentration refers to complex, peptide ligand or elemental copper. These units require conversion before comparison. Additional copper salt can leave a similar colour while changing the metal-to-GHK ratio. After dilution assess precipitate against a medium-only control; copper-associated optical background may also affect colorimetric assays. Include reagent-only, cell-free controls where needed to distinguish optical or chemical interference from biological responses.
What a copper experiment demonstrates
The primary study by Pickart and colleagues in 1980 examined formation of a tripeptide complex with Cu(II) and copper uptake by cultured hepatoma cells. This concerns a mechanism of metal delivery, not a ready-made skin healing assay. The observation depended on metal in the medium. Comparing “GHK-Cu versus nothing” therefore does not establish whether the ligand, copper or their combination is responsible.
For your comparison, prepare a vehicle control, GHK without added copper, a Cu(II) salt and the original complex. Match actual ligand and metal amounts and vehicle. Measuring total cellular copper demonstrates accumulation of the element but does not prove it remains a GHK-Cu complex inside cells. Likewise, altered gene expression does not establish copper speciation in the medium during incubation.
Trial dissolution with equilibrium checks
Before dilution, establish from the COA whether the dry material is a preformed complex, its salt or a formulation containing free GHK. Record peptide content and copper separately. HPLC purity of the organic component alone is insufficient to establish the Cu:GHK ratio. Weighing an unknown mixture and using the molecular weight of an anhydrous complex gives a falsely precise molarity.
Dissolve a small trial portion in a method-compatible vehicle and compare its spectrum before and after transfer to the working matrix. Do not try to preserve blue color by adding a copper salt: this changes composition. In medium containing histidine, other amino acids or albumin, copper distribution can differ from that in an aqueous stock. If using EDTA, record its concentration and include a separate chelator control; it participates in the system rather than acting as a neutral preservative.
Complex mass, ligand and elemental copper
A hypothetical example for verified material: 2.40 mg of complex in a final 3.00 ml gives 0.800 mg/ml of complex. For a final 1.00 ml at 0.0400 mg/ml, take 50.0 µl of stock and add vehicle to 1.00 ml. These numbers do not determine elemental copper concentration until form composition and quantitative content are known. With another salt, the same mass can provide a different number of moles.
If a separate analysis establishes CCu mg/ml of copper, adding 25 µl to a final 1000 µl gives CCu × 0.025 mg/ml copper. This matches a copper control without assuming the entire vial mass is metal. Equal total copper still does not guarantee an equal available fraction in different vehicles. Use separate columns for complex, ligand and metal in the results table.
Two analytical questions rather than one peak
A peptide ligand method may use HPLC or LC-MS; a total copper method, such as ICP-MS, answers a different question. Total metal does not show how much is bound to GHK. Chromatography conditions can themselves change a coordination complex, so free ligand appearing after analysis requires assessment of sample preparation rather than an automatic conclusion that the stock degraded. Assess complex state using a method suitable for that question.
For a colorimetric or fluorescent cellular assay, include GHK-Cu with reagent but no cells, plus medium without complex. Copper may chemically affect the indicator reaction, while its own optical signal changes background. Confirm viability using another compatible method if viability is the endpoint. A result from one redox dye should not immediately be described as stimulation of growth or collagen synthesis.
What to check after storage
For the dry form, follow verified label requirements for temperature and moisture. Open chilled packaging after the closed vial has equilibrated in temperature. Solutions need separate data in the same buffer; a period for copper-free GHK does not establish one for GHK-Cu. If the specification allows frozen aliquots, check ligand recovery and copper system characteristics after thawing, as well as clarity.
Does a changed shade mean lost activity? It may reflect altered coordination or pH and requires analysis. Will extra copper help? It creates another formulation, so without an established procedure this does not restore a batch. Is refrigeration enough? Temperature without data for the particular solution does not establish a storage period. General operations are covered in the storage guide; vehicle selection specifically requires consideration of complex formation.
End of article
GHK-Cu
for laboratory research
Packs and current prices on the product page.